Atlas Trials

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Clinical trial NCT00394628 · UNKNOWN

Trial details

NCT number
NCT00394628
Sponsor
Novacea
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2006-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.